摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-i-Propyl-4,6-di-t-butylpyrimidin | 67490-20-4

中文名称
——
中文别名
——
英文名称
2-i-Propyl-4,6-di-t-butylpyrimidin
英文别名
4,6-di-tert-butyl-2-isopropyl-pyrimidine;4,6-Ditert-butyl-2-propan-2-ylpyrimidine
2-i-Propyl-4,6-di-t-butylpyrimidin化学式
CAS
67490-20-4
化学式
C15H26N2
mdl
——
分子量
234.385
InChiKey
QIANNJOVIMHSRG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED THIAZOLES AND RELATED DERIVATIVES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR[GAMMA]
    申请人:Phenex Pharmaceuticals AG
    公开号:US20150175562A1
    公开(公告)日:2015-06-25
    The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administering these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides carboxamide or sulfonamide containing cyclic compounds of Formula (1), (1′), (100), (100′), (200) and (200′) and the enantiomers, diastereomers, tautomers, /V-oxides, solvates and pharmaceutically acceptable salts thereof.
    本发明提供了用于孤儿核受体RORy的调节剂,并通过向需要治疗RORy介导的疾病的人类或哺乳动物注射这些新型RORy调节剂的方法。具体而言,本发明提供了公式(1)、(1')、(100)、(100')、(200)和(200')的含有羧酰胺或磺酰胺的环状化合物及其对映异构体、互异构体、互变异构体、/V-氧化物、溶剂化物和药学上可接受的盐。
  • CARBOXAMIDE OR SULFONAMIDE SUBSTITUTED NITROGEN-CONTAINING 5-MEMBERED HETEROCYCLES AS MODULATORS FOR THE ORPHAN NUCLEAR RECEPTOR ROR GAMMA
    申请人:PHENEX PHARMACEUTICALS AG
    公开号:US20150344423A1
    公开(公告)日:2015-12-03
    The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administering these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides carboxamide containing cyclic compounds of Formula (1) to Formula (5) and the enantiomers, diastereomers, tautomers, /V-oxides, solvates and pharmaceutically acceptable salts thereof.
    本发明提供了用于孤儿核受体RORy的调节剂,并通过向需要治疗RORy介导的疾病的人类或哺乳动物施用这些新型RORy调节剂来治疗这些疾病的方法。具体而言,本发明提供了公式(1)至公式(5)的含有羧酰胺的环状化合物及其对映体、二对映异构体、互变异构体、/V-氧化物、溶剂化物和药学上可接受的盐。
  • Sulfonylureas and related compounds and use of same
    申请人:THE UNIVERSITY OF QUEENSLAND
    公开号:US11130731B2
    公开(公告)日:2021-09-28
    The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
    本发明提供了某些磺酰类及相关化合物,它们在抑制 NLRP3 炎性体活化方面具有优势特性并显示出有用的活性。此类化合物可用于治疗多种疾病,在这些疾病中,炎症过程或更具体地说是 NLRP3 炎症体被认为是一个关键因素。
  • SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME
    申请人:THE UNIVERSITY OF QUEENSLAND
    公开号:US20180044287A1
    公开(公告)日:2018-02-15
    The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.
  • US9458104B2
    申请人:——
    公开号:US9458104B2
    公开(公告)日:2016-10-04
查看更多